Dashboard
Explore Stocks
Pricing
About
Sign Up
Summary
Intrinsic Value
Fundamental Analysis
Wall Street Estimates
Dividend Analysis
Competition
Ownership
News
Profile Summary
Financials
Income Statement
Balance Sheet
Cash Flow
DCF Valuation
Earnings Call
Dividends
Wall Street Estimates
Read Financial Reports
Stock Analysis Checklist
Ascendis Pharma A/S ASND
Healthcare - Biotechnology - NASDAQ - DK
Watchlist
$ 152.695
-1.28 %
$ 9.14 B
Market Cap
-21.66
P/E
Price Target
Average
27.50%
Revenue Forecast
Estimate
67.70%
EBIT
Estimate
--77.83%
Net Income
Estimate
45.90%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Ascendis Pharma A/S
Wall Street analysts predict an average 1-year price target for
ASND
of
$195
, with forecasts ranging from a low of
$140
to a high of
$289
.
ASND Lowest Price Target
Wall Street Target
140 USD
-8.31%
ASND Average Price Target
Wall Street Target
195 USD
27.50%
ASND Highest Price Target
Wall Street Target
289 USD
89.27%
Price
Max Price Target
Min Price Target
Average Price Target
300
300
280
280
260
260
240
240
220
220
200
200
180
180
160
160
140
140
120
120
100
100
May '24
May '24
Jul '24
Jul '24
Aug '24
Aug '24
Oct '24
Oct '24
Nov '24
Nov '24
2025
2025
Feb '25
Feb '25
Apr '25
Apr '25
Jun '25
Jun '25
Jul '25
Jul '25
Aug '25
Aug '25
Oct '25
Oct '25
Nov '25
Nov '25
2026
2026
Feb '26
Feb '26
REVENUE FORECAST
Revenue Forecast Chart
ASND
$3.0b
$3.0b
$2.5b
$2.5b
$2.0b
$2.0b
$1.5b
$1.5b
$1.0b
$1.0b
$500.0m
$500.0m
$0.0
$0.0
2015
2015
2016
2016
2017
2017
2018
2018
2019
2019
2020
2020
2021
2021
2022
2022
2023
2023
2024
2024
2025
2025
2026
2026
2027
2027
2028
2028
2029
2029
EBIT FORECAST
EBIT Forecast Chart
ASND
$0.0
$0.0
($500.0m)
($500.0m)
($1.0b)
($1.0b)
($1.5b)
($1.5b)
($2.0b)
($2.0b)
($2.5b)
($2.5b)
($3.0b)
($3.0b)
2015
2015
2016
2016
2017
2017
2018
2018
2019
2019
2020
2020
2021
2021
2022
2022
2023
2023
2024
2024
2025
2025
2026
2026
2027
2027
2028
2028
2029
2029
NET INCOME FORECAST
Net Income Chart
ASND
$1.0b
$1.0b
$800.0m
$800.0m
$600.0m
$600.0m
$400.0m
$400.0m
$200.0m
$200.0m
$0.0
$0.0
($200.0m)
($200.0m)
($400.0m)
($400.0m)
($600.0m)
($600.0m)
2015
2015
2016
2016
2017
2017
2018
2018
2019
2019
2020
2020
2021
2021
2022
2022
2023
2023
2024
2024
2025
2025
2026
2026
2027
2027
2028
2028
2029
2029
Upgrade a Plan
If you need more info, please check
Pricing Guidelines
.
Free
forever, no credit card required
$
0
/ Mon
Up to 3 Valuations Access per week
Only 1 Watchlist
Select
Unlimited Plan
No restrictions, no limits.All stocks, all tools.
$
15.00
/ month
All stocks, all tools.
No restrictions, no limits.
Select Plan
Premium Plan
Enough to check your investmentsfrom time to time.
$
9.00
/ month
15 stocks per week
Enough to check investments
Select Plan
Add Note
Capture your thoughts
Note
Sell
Buy
Hold
Pass